openPR Logo
Press release

Global HIV-AIDS Testing Market Revenue to Witness Steady Growth Through 2020

01-04-2019 05:25 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global HIV-AIDS Testing Market Revenue to Witness Steady Growth

HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease. HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue. HIV-AIDS has no cure but there are treatments which help to reduce AIDS deaths. HIV-AIDS can be treated by nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor. Some of the drugs for HIV -AIDS treatment include atripla, epzicom, prezista, truvada, kaletra, isentress, reyataz and viread. HIV testing and diagnostics include early detection, treatment swatching, On the basis of diagnosis HIV-AIDS market can be classified into HIV antibody assay, western blot, antigen-antibody immunoassay, HIV home-testing kit, rapid HIV antibody test, polymerase chain reaction test and HIV p24 antigen test.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/3270

Europe, followed by North America, has the largest market for HIV-AIDS testing due to affordability and accessibility of expensive tests for HIV-AIDS and innovations in drug therapies in this region. Asia is expected to show high growth rate in the HIV-AIDS testing market in next few years due to increasing number of HIV-AIDS population and increasing research activities for developing HIV drugs and vaccines in the region.

Increasing number of HIV patients, technological advancement in HIV-AIDS diagnosis, increasing incidence of infectious diseases, rise in research activities for developing HIV vaccines and lack of awareness about the modes of transmission of the virus are expected to drive the market for HIV-AIDS testing. In addition, increasing awareness about HIV aids treatment options available in the market and cost effective drug therapies for HIV is expected to drive the HIV-AIDS testing market. However, rapid replacement of HIV-AIDS drugs and therapies by new drugs and therapies and patient protection losses are some of the factors restraining the growth for global HIV-AIDS testing market.

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in HIV-AIDS testing market in Asia. In addition, rise in awareness about HIV-AIDS treatment and innovations in technologies related to HIV-AIDS testing are expected to offer new opportunity to global HIV-AIDS testing market. Companies involved in new product launch is one the recent trends have been observed in global HIV-AIDS testing market. Some of the major companies operating in the global HIV AIDS market are Abbott Laboratories Inc., Hologic Inc., Siemens Healthcare Diagnostics Inc., Bio-Rad Laboratories Inc., Roche Diagnostics Inc. and Ortho-Clinical Diagnostics Inc.

Request Report TOC@ https://www.persistencemarketresearch.com/methodology/3270

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global HIV-AIDS Testing Market Revenue to Witness Steady Growth Through 2020 here

News-ID: 1469856 • Views:

More Releases from Persistence Market Research

Prostate Cancer Hormone Therapy Market Projected to Grow at 20.9% CAGR During 2025-2032 | Persistence Market Research
Prostate Cancer Hormone Therapy Market Projected to Grow at 20.9% CAGR During 20 …
The prostate cancer hormone therapy market has evolved into one of the most critical segments within global oncology therapeutics, driven by the rising prevalence of prostate cancer and continuous innovation in hormone-based treatment approaches. Prostate cancer remains one of the most commonly diagnosed malignancies among men worldwide, particularly affecting aging populations in both developed and developing regions. Hormone therapy, also known as androgen deprivation therapy (ADT), has long been the
Telehealth Market Valued at US$ 219.6 Billion in 2025, Poised for Exponential Growth Through 2032 | Persistence Market Research
Telehealth Market Valued at US$ 219.6 Billion in 2025, Poised for Exponential Gr …
The global telehealth market has evolved from a complementary healthcare solution into a core pillar of modern medical delivery systems. Telehealth broadly refers to the use of digital communication technologies-such as video conferencing, mobile applications, web-based platforms, and remote monitoring tools-to deliver healthcare services at a distance. What once served as a niche solution for rural or underserved populations has now become an integral component of mainstream healthcare, reshaping how
Therapeutic Albumin Market Valued at US$ 4.71 Bn in 2025, Expected to Reach US$ 6.90 Bn by 2032 | Persistence Market Research
Therapeutic Albumin Market Valued at US$ 4.71 Bn in 2025, Expected to Reach US$ …
The therapeutic albumin market represents a vital segment of the global biopharmaceutical and plasma protein industry, underpinned by albumin's indispensable role in critical care, chronic disease management, and advanced biomedical applications. Albumin, the most abundant plasma protein in human blood, is widely used for its ability to maintain oncotic pressure, stabilize blood volume, transport endogenous and exogenous substances, and support physiological homeostasis. Clinically, therapeutic albumin is a cornerstone in the
Wire Extrusion Machine Market to Reach US$ 2.5 Bn by 2033, Says Persistence Market Research
Wire Extrusion Machine Market to Reach US$ 2.5 Bn by 2033, Says Persistence Mark …
The global wire extrusion machine market has emerged as a critical segment in the industrial machinery and cable manufacturing ecosystem. Wire extrusion machines are specialized equipment used to coat, insulate, and finish metal wires with polymeric or thermoplastic materials, ensuring durability, electrical insulation, and resistance to environmental factors. These machines are integral to the production of wires and cables for sectors such as power generation, telecommunications, automotive, construction, and renewable

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways